rfhg_74138.1

Basic information about the TSS

---

TSS ID: rfhg_74138.1 Species: human Chr: chr5		Start: 150446853 End: 150446935 Strand: -
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS (EH38D3776489,EH38E2421000)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000519855.1:-2 GeneID: 6208 HGNC/MGI_ID: HGNC:10387 UniProt_ID: Nearer transcript ids and distances:

Gene_name: RPS14 Gene_symbol: RPS14 Gene_synonyms: EMTB S14 Gene_source: HGNC:10387

TATA-Box annotation

---

Distance to TSS:	2845
Nearest PromoterID:	NM_001025070
Entrez ID:	6208
Nearest Unigene:	Hs.744846
Nearest Refseq:	NM_005617
Nearest Ensembl:	ENSG00000164587
Gene Name:	RPS14
Gene Alias:	EMTB|S14
Gene Type:	protein-coding
CpG%:	0.012195
GC%:	0.530120
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPS14 p2@RPS14 p3@RPS14 p4@RPS14
Sample		p1@RPS14	p2@RPS14	p3@RPS14	p4@RPS14
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	75.97	20.06	2.92	13.64
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	89.42	26.30	5.06	17.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	89.12	24.88	4.63	15.05
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	67.57	21.00	4.57	12.06
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	73.34	27.90	4.95	12.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	71.71	16.86	4.65	10.47
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	118.31	25.27	12.64	13.51
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	80.66	22.77	3.39	14.78
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	78.86	27.78	4.49	19.45
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	58.54	10.43	2.90	6.38
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	44.87	13.34	2.83	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	47.16	10.16	1.63	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	85.92	2.58	4.51	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	95.47	1.35	5.71	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	115.05	3.07	4.39	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	80.98	1.76	2.51	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	86.49	1.31	3.93	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	83.94	1.69	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	92.24	1.60	5.33	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	125.02	3.61	5.72	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	108.53	3.07	4.28	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	118.07	2.42	6.04	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	103.28	2.46	3.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	93.43	2.67	4.61	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	94.42	2.84	3.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	133.88	1.58	4.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	104.40	2.20	4.40	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	114.81	4.72	6.37	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	103.38	4.52	7.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	100.98	4.16	4.52	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	99.86	2.93	6.28	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	104.72	3.13	5.86	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	105.94	1.27	6.75	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	178.63	2.14	7.42	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	107.33	1.68	4.67	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	86.04	2.11	6.13	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	99.53	3.88	5.72	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	100.14	3.02	6.45	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	131.54	1.62	7.83	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	117.15	3.60	5.04	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	92.93	4.23	5.88	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	126.05	1.46	8.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	77.61	3.59	4.22	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	87.24	2.27	4.20	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	123.27	2.81	3.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	124.93	3.49	4.42	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	83.97	4.08	4.32	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	134.72	2.68	7.75	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	90.48	1.20	4.07	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	101.91	1.82	6.67	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	75.63	1.84	3.28	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	83.61	3.11	5.34	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	559.69	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	52.87	1.77	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	53.68	2.98	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	561.25	5.03	4.19	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	181.86	1.38	8.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	52.18	2.27	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	54.28	1.93	2.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	171.94	3.14	2.83	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	52.17	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	46.55	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	210.18	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	107.37	3.74	2.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	45.16	2.60	2.27	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	43.66	2.13	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	468.75	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	710.77	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	36.08	2.93	2.44	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	45.62	2.98	2.48	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	40.81	2.81	2.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	51.00	5.30	3.31	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.24	2.17	1.86	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	35.16	2.14	1.83	0.31
Adipocyte - breast, donor1	11376-118A8	25.97	3.17	2.38	0.32
Adipocyte - breast, donor2	11327-117E4	25.67	2.25	1.60	0.32
Adipocyte - omental, donor1	11473-119C6	21.88	2.80	2.04	0.13
Adipocyte - omental, donor2	11474-119C7	40.36	3.74	3.74	0.75
Adipocyte - omental, donor3	11475-119C8	34.83	3.35	2.68	1.00
Adipocyte - perirenal, donor1	11476-119C9	49.76	5.74	3.83	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	4.40	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	28.00	5.87	0.90	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	61.52	3.65	2.61	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	34.23	6.65	1.56	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	18.53	3.86	1.80	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	20.63	5.30	1.39	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	27.04	8.23	3.53	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	37.48	4.58	1.45	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	25.17	4.20	1.61	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	4.27	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	4.45	3.34	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	13.72	3.74	1.25	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	18.84	2.26	2.26	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	15.38	3.27	2.62	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.83	5.48	1.83	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	40.00	18.78	5.75	4.20
Alveolar Epithelial Cells, donor2	11590-120G6	50.20	44.11	18.29	23.31
Alveolar Epithelial Cells, donor3	11671-122G6	39.53	7.19	4.79	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	26.81	8.10	4.14	1.98
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	42.53	8.01	2.05	2.47
Anulus Pulposus Cell, donor1	11248-116E6	54.58	1.60	2.40	0.00
Anulus Pulposus Cell, donor2	11463-119B5	57.06	5.14	3.18	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	28.75	4.94	4.49	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	38.20	5.64	3.47	3.91
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	36.17	5.98	2.69	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	10.12	7.59	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	45.54	5.28	5.94	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	42.56	6.82	3.25	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	40.29	6.31	2.43	3.88
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	61.17	6.53	2.97	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	62.90	7.16	4.14	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	5.81	4.35	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	41.37	6.27	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.17	4.12	5.11	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	2.73	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	59.56	7.09	3.92	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	27.86	4.29	3.21	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	49.88	5.48	3.40	3.02
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	46.78	5.35	5.08	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	6.83	9.75	3.90	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	57.22	7.13	3.65	2.32
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	48.03	10.81	9.61	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	41.68	4.97	3.77	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	41.26	7.77	3.40	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	53.12	7.59	2.66	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	39.98	7.27	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	48.45	6.84	2.28	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	40.62	6.41	4.49	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	49.30	5.94	3.10	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	34.72	8.45	2.82	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	45.34	3.86	4.50	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	55.65	5.71	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	33.93	7.02	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	36.13	7.53	3.31	3.01
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	67.72	11.88	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	47.30	7.12	3.56	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	53.74	9.42	4.58	2.29
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	45.75	8.90	5.72	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	40.56	3.45	3.02	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	50.80	8.26	3.60	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	42.63	4.64	3.19	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	3.78	3.78	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	44.59	4.24	3.73	2.20
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	4.63	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	4.23	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	42.24	5.36	3.43	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	39.11	7.22	3.01	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	34.26	5.83	2.92	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	59.77	5.06	3.22	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	12.75	7.65	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	59.49	8.39	3.81	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	44.80	6.19	4.54	2.89
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	42.84	7.96	3.06	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	40.15	11.47	3.35	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	45.68	7.54	3.77	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	6.10	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	42.10	6.65	3.88	5.54
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	35.22	5.03	3.44	2.65
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	47.98	5.45	4.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	28.12	7.86	4.67	3.07
Astrocyte - cerebellum, donor2	11580-120F5	44.50	15.40	5.13	5.65
Astrocyte - cerebellum, donor3	11661-122F5	11.96	6.08	1.47	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	71.11	8.37	2.79	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.00	12.94	7.28	5.18
Astrocyte - cerebral cortex, donor3	11392-118C6	56.38	8.95	4.92	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	85.67	10.90	7.57	3.21
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	73.29	16.54	8.02	6.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	70.33	11.38	9.79	5.01
Basophils, donor1	12241-129G9	68.00	0.26	4.71	0.00
Basophils, donor2	12242-129H1	108.60	0.36	1.08	0.36
Basophils, donor3	12243-129H2	68.06	0.15	1.32	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	49.59	5.61	4.74	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	64.01	20.57	5.03	3.66
Bronchial Epithelial Cell, donor3	11672-122G7	114.78	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	59.63	46.45	16.95	28.24
Bronchial Epithelial Cell, donor5	11457-119A8	51.16	39.30	9.77	16.43
Bronchial Epithelial Cell, donor6	11461-119B3	52.97	9.90	6.68	2.07
Bronchial Epithelial Cell, donor7	11769-123I5	55.78	4.32	4.86	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	114.49	9.58	6.49	3.19
Burkitt's lymphoma cell line:RAJI	10476-106I8	129.96	14.67	8.62	3.96
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	247.51	4.16	10.87	3.52
CD133+ stem cells - cord blood derived, pool1	12223-129E9	227.52	10.34	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	68.75	1.69	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	31.18	0.19	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	43.25	0.00	1.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.82	2.26	2.83	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	32.60	1.52	3.79	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	46.35	1.64	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	51.60	0.29	1.30	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	29.87	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	27.24	0.00	1.90	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	35.15	0.17	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.29	0.00	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	28.26	0.00	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	51.69	0.00	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	41.66	0.18	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	45.92	0.65	1.52	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.78	0.70	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	34.32	0.53	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	46.56	0.15	1.19	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.14	0.40	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	46.01	0.42	2.08	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	56.28	0.00	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.20	0.45	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.79	0.44	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	36.31	0.27	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	38.21	0.17	1.05	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	33.67	0.84	2.10	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	32.33	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	32.76	0.35	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	22.81	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	33.65	0.35	1.05	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.76	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	57.34	0.43	1.72	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	40.95	0.00	2.05	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	23.88	0.00	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	38.74	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	44.03	0.22	4.14	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	67.45	0.69	5.54	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	63.47	0.43	3.90	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	78.95	0.16	4.20	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	53.27	0.35	3.84	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	23.63	0.00	1.34	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	157.19	0.77	8.42	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	85.41	0.22	3.51	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	60.85	0.21	3.79	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	227.62	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	222.38	2.03	2.71	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	195.73	3.11	8.28	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	268.12	3.20	4.80	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	254.63	2.14	9.11	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	193.73	3.51	9.83	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	194.52	3.14	5.49	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	262.34	3.95	6.59	0.00
CD19+ B Cells, donor1	11544-120B5	53.42	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	55.13	0.00	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	73.70	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	20.61	3.23	5.66	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.17	5.19	6.39	0.40
CD34+ Progenitors, donor1	11545-120B6	211.85	0.00	3.01	1.00
CD34+ Progenitors, donor2	11625-122B5	103.37	2.25	3.93	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	232.22	9.77	10.90	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	230.89	11.27	14.21	2.71
CD4+ T Cells, donor1	11225-116C1	149.25	0.71	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	143.91	1.22	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	115.59	0.30	2.13	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	86.01	0.51	2.81	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	109.60	1.12	5.39	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	96.01	2.01	5.46	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	408.67	0.00	3.79	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	480.39	2.11	7.73	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	164.81	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	56.65	0.72	1.73	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	91.85	1.69	4.24	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	80.44	1.29	4.35	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	155.11	1.34	5.38	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	145.00	0.00	4.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	66.88	1.32	2.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	64.09	1.26	4.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	95.37	0.21	5.19	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	94.22	0.33	6.01	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	229.51	0.54	4.35	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	248.68	1.61	11.25	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	139.87	0.00	8.97	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	96.79	3.15	4.45	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	73.65	1.73	3.47	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	52.96	1.47	2.31	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	270.50	1.52	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	257.78	1.30	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	85.86	0.87	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	377.59	3.96	5.44	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	338.81	3.69	7.39	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	395.02	2.79	6.98	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	148.99	3.05	5.26	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	154.84	1.47	5.15	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	274.12	3.08	7.70	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	261.43	2.51	5.73	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	292.23	4.15	6.92	0.00
CD8+ T Cells, donor1	11226-116C2	158.13	0.65	1.64	0.00
CD8+ T Cells, donor2	11307-117C2	95.36	1.50	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	141.14	2.27	2.78	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	72.49	3.44	4.36	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	51.04	2.64	6.23	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	64.84	3.83	6.84	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	102.67	4.50	6.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	51.60	3.84	4.80	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	60.03	2.50	3.41	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	65.84	8.69	5.65	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	64.48	6.05	4.47	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	58.39	6.57	8.21	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	74.26	11.17	8.75	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	66.82	6.10	9.88	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.87	8.26	4.80	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	55.59	3.50	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	65.13	4.10	3.64	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	44.01	4.48	2.24	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	63.39	4.68	2.52	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	63.59	4.60	3.16	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	70.47	4.24	6.60	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	66.23	7.29	5.07	2.22
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	66.74	9.84	5.23	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	67.64	8.98	6.09	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	71.14	9.56	7.65	4.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	66.21	7.88	5.91	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	71.86	5.29	6.81	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	51.39	1.61	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	60.15	2.80	1.40	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	53.09	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	12.79	0.00	5.48
Cardiac Myocyte, donor2	11605-120I3	29.65	4.94	1.48	2.47
Cardiac Myocyte, donor3	11686-122I3	86.50	10.52	2.42	2.63
Chondrocyte - de diff, donor1	11261-116G1	23.57	5.55	5.20	1.73
Chondrocyte - de diff, donor2	11338-117F6	40.87	4.26	1.42	1.07
Chondrocyte - de diff, donor3	11410-118E6	47.79	1.93	2.96	0.11
Chondrocyte - re diff, donor2	11339-117F7	27.75	2.69	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	52.17	3.64	1.62	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	79.53	8.49	5.28	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	55.79	13.04	6.41	3.42
Ciliary Epithelial Cells, donor3	11399-118D4	58.05	9.91	4.25	3.10
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.17	2.84	3.30	0.64
Corneal Epithelial Cells, donor1	11526-119I5	35.13	8.12	4.61	0.88
Corneal Epithelial Cells, donor2	11606-120I4	32.99	12.51	7.96	4.55
Corneal Epithelial Cells, donor3	11687-122I4	49.85	17.38	9.97	3.32
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.21	1.82	3.63	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	59.61	1.26	3.47	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.75	3.67	3.56	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	107.96	1.37	5.12	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	136.45	0.65	7.18	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	76.95	1.45	7.74	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	40.86	13.51	2.33	2.84
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	17.60	1.17	7.63
Endothelial Cells - Aortic, donor2	11340-117F8	37.89	23.75	1.98	7.35
Endothelial Cells - Aortic, donor3	11412-118E8	46.79	16.91	0.79	4.72
Endothelial Cells - Artery, donor1	11264-116G4	36.94	9.89	2.33	3.49
Endothelial Cells - Artery, donor2	11341-117F9	44.23	18.12	6.59	6.35
Endothelial Cells - Artery, donor3	11413-118E9	56.45	17.53	3.33	7.01
Endothelial Cells - Lymphatic, donor1	11236-116D3	68.05	5.32	0.66	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	27.38	3.96	1.52	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.66	3.95	0.56	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	34.17	10.10	1.49	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	56.75	9.89	3.12	4.17
Endothelial Cells - Microvascular, donor3	11414-118F1	54.87	2.41	1.42	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	27.21	16.00	3.20	8.00
Endothelial Cells - Thoracic, donor2	11343-117G2	44.03	13.63	1.05	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	54.05	8.82	4.10	2.98
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.63	17.38	3.26	6.52
Endothelial Cells - Umbilical vein, donor3	11400-118D5	40.55	19.05	2.20	4.27
Endothelial Cells - Vein, donor1	11267-116G7	38.68	21.61	6.83	15.93
Endothelial Cells - Vein, donor2	11344-117G3	34.93	17.46	3.49	4.89
Endothelial Cells - Vein, donor3	11416-118F3	60.76	20.72	3.61	5.02
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	29.70	0.00	3.30	0.00
Eosinophils, donor3	12246-129H5	32.10	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.40	4.89	3.91	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	6.24	4.16	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.34	6.57	2.05	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.35	2.96	4.60	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	67.93	5.63	6.83	1.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	48.75	8.25	5.34	1.82
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.92	5.32	1.77	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	43.03	4.01	2.95	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.23	2.37	1.84	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	46.51	5.65	4.32	1.99
Fibroblast - Cardiac, donor1	11268-116G8	31.75	16.33	3.18	7.71
Fibroblast - Cardiac, donor2	11345-117G4	62.15	12.13	3.79	3.79
Fibroblast - Cardiac, donor3	11417-118F4	46.37	7.89	4.42	3.31
Fibroblast - Cardiac, donor4	11452-119A3	23.34	4.85	1.52	0.30
Fibroblast - Cardiac, donor5	11456-119A7	41.12	10.41	4.19	3.43
Fibroblast - Cardiac, donor6	11460-119B2	39.11	15.46	4.85	5.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	20.10	4.42	1.88	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.20	6.04	0.86	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	14.65	4.39	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	30.44	13.38	3.69	2.31
Fibroblast - Conjunctival, donor3	11692-122I9	55.80	2.37	1.53	0.00
Fibroblast - Dermal, donor1	11269-116G9	38.74	8.92	6.57	3.52
Fibroblast - Dermal, donor2	11346-117G5	44.34	18.40	8.02	7.55
Fibroblast - Dermal, donor3	11418-118F5	70.36	7.01	5.44	1.57
Fibroblast - Dermal, donor4	11450-119A1	43.52	13.57	9.27	3.50
Fibroblast - Dermal, donor5	11454-119A5	41.69	13.78	9.77	5.23
Fibroblast - Dermal, donor6	11458-119A9	46.62	22.58	9.26	6.01
Fibroblast - Gingival, donor1	11237-116D4	48.93	5.62	3.96	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	32.23	2.10	2.62	1.05
Fibroblast - Gingival, donor2	11318-117D4	54.69	10.41	6.19	2.50
Fibroblast - Gingival, donor3	11394-118C8	33.07	2.03	1.26	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	40.52	6.23	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	31.89	3.17	1.76	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.82	5.92	3.90	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.99	5.41	6.49	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	2.12	2.12	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	32.03	5.85	3.80	1.32
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	31.91	4.64	5.45	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	32.91	12.07	6.80	4.28
Fibroblast - Gingival, donor9 (control)	11927-125I1	45.20	1.61	2.05	0.00
Fibroblast - Lung, donor1	11270-116H1	50.30	9.52	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	17.91	5.97	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	62.04	9.50	6.75	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	19.16	5.00	6.66	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	6.99	2.80	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	20.15	4.76	3.08	1.68
Fibroblast - Mammary, donor1	11540-120B1	18.27	8.12	2.44	1.62
Fibroblast - Mammary, donor2	11620-122A9	7.99	11.98	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	11.91	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	69.64	12.22	6.60	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	44.44	7.43	4.25	2.73
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.89	4.28	1.53	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	6.49	3.05	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	56.16	7.02	3.78	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	42.68	5.22	1.74	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	73.95	23.21	6.96	7.52
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.86	5.69	1.83	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	14.70	6.01	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	51.40	8.30	4.35	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.15	1.59	1.79	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	34.81	2.49	1.42	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	41.98	5.52	2.37	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.94	3.01	3.01	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	27.85	4.21	3.56	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.34	2.78	2.02	1.27
Fibroblast - skin normal, donor1	11553-120C5	27.40	3.77	1.97	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.45	4.21	1.40	1.40
Fibroblast - skin normal, donor2	11561-120D4	28.83	4.92	3.82	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.09	1.51	1.51	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	45.07	3.73	1.66	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.49	3.25	2.56	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.87	1.64	0.99	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.64	4.05	5.75	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	29.35	8.77	3.71	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	116.67	2.67	3.29	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	576.15	0.00	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	66.24	6.10	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	31.90	10.23	3.81	3.47
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.27	13.27	1.30	3.64
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.15	12.52	4.60	5.88
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	139.33	84.21	24.50	32.92
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	171.00	79.76	26.16	28.08
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	224.22	98.42	28.81	58.19
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	186.14	18.75	7.72	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	97.27	13.01	5.02	5.25
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	149.59	66.77	18.82	31.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	185.83	17.18	8.46	5.82
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	104.04	13.70	6.20	5.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	120.28	100.38	21.67	45.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	56.81	27.28	10.88	10.60
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.72	24.51	6.40	12.81
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	81.93	27.40	11.28	19.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.89	14.25	4.34	4.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	39.04	19.79	5.54	6.23
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	58.14	18.09	10.37	8.95
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.73	9.13	5.93	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.46	11.34	3.24	2.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.33	12.90	3.72	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	77.42	7.68	5.02	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.01	15.74	4.61	2.54
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	64.79	9.61	4.02	6.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	56.86	5.24	4.44	2.42
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.27	12.72	3.90	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.97	8.78	3.37	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.78	5.93	3.12	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.45	4.61	1.20	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	43.71	8.96	1.88	3.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.35	9.32	4.74	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.53	8.78	3.88	2.25
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	74.27	5.16	3.09	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.47	7.61	2.42	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.53	10.17	3.17	2.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.01	4.85	1.10	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	55.84	7.50	2.46	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	46.20	9.08	4.05	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	46.50	5.45	3.53	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.81	7.77	1.80	1.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	36.06	8.54	3.95	3.01
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.79	5.47	1.82	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.13	9.20	3.14	4.08
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.03	6.81	1.76	2.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.97	7.57	1.12	3.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.91	7.59	1.39	2.31
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.60	12.03	4.28	2.94
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.94	11.32	2.75	5.36
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	24.22	12.31	1.94	4.40
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.87	7.86	1.90	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.10	5.16	0.37	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	44.08	6.36	3.29	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	5.95	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.02	4.75	1.32	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	36.92	3.43	1.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.72	1.52	1.02	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	49.57	47.58	19.71	21.50
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	57.47	31.59	11.56	14.33
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.37	45.62	10.43	22.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	129.55	65.72	13.46	31.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	125.74	70.07	18.65	26.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	64.57	60.88	13.37	25.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	34.65	17.32	32.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	85.48	46.80	13.15	22.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	57.76	6.42	33.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	79.99	41.73	8.69	15.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	85.93	42.96	6.51	23.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	67.95	46.12	11.53	17.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	26.66	3.33	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	81.38	38.03	7.27	11.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	57.85	30.40	9.48	17.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	59.56	11.74	1.68	9.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	73.16	35.62	6.36	10.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	73.37	28.19	10.19	15.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	141.99	45.94	10.44	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.63	30.93	9.74	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	71.04	22.49	6.51	7.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	123.67	23.72	3.39	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	72.90	42.25	6.63	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	69.04	28.08	7.13	11.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	110.64	26.34	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	66.50	23.45	3.46	8.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	84.43	19.56	5.22	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	121.73	24.75	4.01	6.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	100.94	15.41	4.24	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	65.39	20.88	5.82	9.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	106.85	12.42	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	120.79	14.16	6.13	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	97.16	19.31	3.62	3.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	128.19	18.82	5.09	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	110.48	12.36	5.98	6.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	109.03	17.76	8.39	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	134.57	28.33	7.08	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	147.03	21.59	12.25	5.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	91.29	17.12	12.29	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	97.48	16.11	5.93	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	79.99	19.70	2.98	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	89.77	27.17	7.28	5.34
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	9.13	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	29.52	4.16	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	50.60	17.99	10.12	14.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	33.30	3.17	1.59	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	60.99	2.51	4.18	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	60.81	15.43	8.70	5.34
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.09	12.66	6.41	4.73
Hep-2 cells mock treated, biol_rep3	11900-125F1	40.27	10.92	2.96	4.32
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.39	13.01	7.65	4.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	30.52	12.04	5.59	4.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.22	10.55	5.38	5.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	66.38	12.45	7.97	4.61
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	34.65	8.92	5.83	4.46
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	32.68	12.81	4.49	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	23.50	6.16	1.68	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	30.30	13.85	4.33	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	13.22	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	32.45	8.82	1.76	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	41.41	7.99	3.63	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.49	20.63	5.07	8.39
Hepatocyte, donor1	11523-119I2	20.58	2.42	1.21	1.21
Hepatocyte, donor2	11603-120I1	6.46	6.46	1.08	3.23
Hepatocyte, donor3	11684-122I1	27.00	6.75	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.30	9.14	7.18	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	50.34	8.04	3.67	3.67
Iris Pigment Epithelial Cells, donor1	11530-119I9	48.43	9.19	3.02	4.25
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	47.76	12.74	19.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	20.03	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	51.22	42.92	15.23	9.69
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	17.52	5.01	12.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	35.60	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	41.01	7.69	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	13.71	9.14	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	32.49	17.87	19.49
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	28.34	5.00	23.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	14.52	10.89	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	31.76	27.79	11.91	22.50
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	41.02	26.61	11.09	12.20
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	15.71	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	61.10	28.97	13.23	15.12
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	58.77	26.29	10.83	17.01
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	56.21	23.90	16.15	13.57
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	53.13	49.91	14.49	16.10
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	56.23	36.67	13.85	8.96
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	52.48	20.15	15.11	6.30
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	49.02	23.31	19.29	8.84
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	46.16	29.55	12.00	6.46
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	55.23	27.85	10.38	12.27
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	52.60	34.47	12.70	9.98
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	52.73	30.13	9.69	12.91
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	66.06	35.57	16.52	19.06
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	28.06	14.03	6.38
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	51.03	20.05	14.58	16.40
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.13	24.99	15.00	11.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	26.55	13.27	13.27
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	62.55
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	40.43	26.85	9.88	9.88
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	28.10	12.29	21.07
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	3.14	3.14	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	18.78	11.13	11.13
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	24.34	8.85	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	19.45	3.24	12.97
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	22.67	16.57	8.72
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	40.50	13.50	18.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	10.45	3.48	20.91
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	59.74	13.87	12.80	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	26.32	15.24	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	28.50	17.10	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	47.86	25.77	13.81	11.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	15.13	21.18	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	31.04	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	51.81	6.34	5.29	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.62	6.36	2.28	1.31
Keratinocyte - epidermal, donor2	11349-117G8	40.41	8.78	6.44	4.10
Keratinocyte - epidermal, donor3	11421-118F8	39.09	11.07	5.68	3.50
Keratinocyte - oral, donor1	11251-116E9	77.99	5.56	7.15	0.57
Keratocytes, donor1	11527-119I6	40.92	16.16	4.47	0.34
Keratocytes, donor2	11607-120I5	25.78	10.55	3.52	2.34
Keratocytes, donor3	11688-122I5	32.80	7.51	1.19	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	12.94	5.39	5.39
Lens Epithelial Cells, donor2	11609-120I7	57.90	2.65	2.54	0.35
Lens Epithelial Cells, donor3	11690-122I7	42.08	11.40	2.22	4.14
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.79	3.32	2.61	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	45.77	7.54	1.40	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.41	4.09	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	33.34	5.91	1.08	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	61.46	5.04	2.52	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	43.66	5.71	2.37	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.14	4.10	1.23	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	53.09	5.31	1.26	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	41.94	5.49	2.25	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.99	4.35	2.37	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.14	3.30	2.52	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	49.99	7.78	1.48	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	35.89	5.92	2.09	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	43.17	4.05	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	35.16	5.77	1.37	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.26	3.70	2.16	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	48.01	6.55	3.12	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	36.96	5.12	1.28	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.58	5.92	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	39.24	3.51	0.59	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	38.34	4.23	2.74	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	43.65	4.36	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	47.67	1.35	2.96	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	33.15	4.54	1.21	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	43.55	5.18	0.52	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.81	6.07	1.26	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	34.59	4.81	1.50	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	38.52	8.25	4.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	39.32	3.39	3.57	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	41.35	4.35	1.06	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.28	2.42	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	49.62	4.63	2.98	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.46	4.96	1.36	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	32.21	4.81	1.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	44.72	4.69	1.98	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	39.87	4.26	1.51	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.63	5.47	1.29	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.65	3.35	2.43	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.11	3.36	1.12	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	43.73	4.27	3.20	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	29.09	6.30	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	43.73	5.60	1.71	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.55	5.37	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.65	3.27	1.96	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	47.32	6.36	2.12	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	28.96	3.84	1.36	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	37.39	4.10	1.79	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.31	4.77	0.90	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	63.45	13.60	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	85.92	15.34	3.84	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.88	7.42	2.97	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	63.47	8.46	5.92	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	55.56	6.33	4.22	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	6.54	4.67	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	44.83	5.67	7.21	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	63.04	5.95	3.57	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	79.85	9.27	7.24	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	53.80	9.89	5.23	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	55.82	5.40	4.05	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	60.83	6.91	5.42	2.30
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	58.03	6.16	7.70	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	61.40	9.88	6.00	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	26.65	4.00	2.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.96	10.70	5.60	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	63.77	8.27	5.07	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	70.10	10.39	5.29	3.02
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	63.20	7.36	7.36	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.05	11.42	4.89	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	77.47	12.91	4.79	2.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	69.50	10.09	6.73	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	59.76	11.33	5.15	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	76.93	12.19	6.97	4.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	57.10	7.17	6.28	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	7.75	3.87	3.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	77.41	8.48	3.53	6.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	52.74	7.01	5.16	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	59.87	11.51	6.91	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	72.91	14.97	5.76	4.99
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	47.55	12.45	7.36	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	59.07	9.03	5.74	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.91	10.85	6.33	7.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	81.15	12.93	4.31	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.83	9.71	1.49	3.73
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.49	10.03	6.32	5.95
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	72.37	12.06	7.32	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.09	6.85	5.14	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.97	9.33	4.66	5.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	69.98	6.64	5.43	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	49.77	8.53	8.53	9.24
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	78.71	10.66	5.84	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	61.19	11.81	4.29	3.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	65.32	8.08	3.37	6.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	71.86	13.33	8.15	5.93
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	80.24	9.30	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	63.46	8.46	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	70.43	10.00	8.40	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	60.33	9.45	5.09	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	101.18	9.96	6.13	8.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	72.51	9.87	6.41	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	10.35	2.82	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	98.05	16.09	6.54	5.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	71.65	9.01	4.96	5.86
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	44.75	6.88	13.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	83.72	10.24	5.79	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	55.92	10.56	6.26	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	59.38	5.28	5.28	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	89.77	14.53	3.11	7.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	59.95	7.00	7.44	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	63.74	8.95	5.59	3.91
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.97	15.46	3.53	3.97
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.60	13.50	2.70	4.63
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	62.79	15.19	5.06	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	66.33	12.02	6.25	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	60.43	9.94	6.36	5.17
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	45.57	4.86	6.68	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	52.57	9.68	9.68	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	81.32	15.20	7.60	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	58.36	12.39	7.75	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	31.44	13.30	12.09	4.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.55	12.99	5.70	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	53.31	10.66	4.80	5.86
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	41.95	12.64	13.79	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	76.11	13.37	6.17	6.17
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	58.00	11.32	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.13	20.43	14.19	5.67
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	69.06	14.56	3.74	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	57.16	8.61	1.57	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	47.18	13.78	10.02	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	64.58	13.01	2.79	7.43
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.29	10.70	9.37	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	40.10	17.11	10.16	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.35	13.74	6.47	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	69.75	9.18	5.51	7.34
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.90	11.56	4.45	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	82.63	12.54	3.99	6.84
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	52.15	11.50	4.60	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	30.09	15.87	9.30	7.11
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	69.94	16.04	5.35	7.57
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	91.50	17.16	9.10	4.42
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	43.10	23.87	17.24	12.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	8.31	4.16	6.24
Macrophage - monocyte derived, donor1	11232-116C8	33.73	2.28	2.96	0.00
Macrophage - monocyte derived, donor2	11313-117C8	21.65	1.65	4.22	0.37
Macrophage - monocyte derived, donor3	11389-118C3	29.89	2.36	3.93	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	53.10	16.99	6.37	2.12
Mallassez-derived cells, donor2	11929-125I3	18.86	6.02	2.06	1.74
Mallassez-derived cells, donor3	11930-125I4	25.71	10.29	4.03	4.31
Mammary Epithelial Cell, donor1	11273-116H4	60.08	8.27	3.99	1.30
Mammary Epithelial Cell, donor2	11350-117G9	35.33	6.66	4.34	1.16
Mammary Epithelial Cell, donor3	11422-118F9	77.07	17.46	6.73	6.49
Mast cell - stimulated, donor1	11487-119E2	21.69	1.36	0.68	0.00
Mast cell, donor1	11563-120D6	44.77	0.87	2.27	0.32
Mast cell, donor2	11565-120D8	87.37	0.30	4.46	0.00
Mast cell, donor3	11566-120D9	120.67	0.68	2.48	0.00
Mast cell, donor4	11567-120E1	80.67	0.89	2.66	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	28.39	1.77	3.88	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	34.44	2.33	4.09	0.00
Mast cell, expanded, donor5	11939-126A4	52.54	0.23	4.24	0.00
Mast cell, expanded, donor8	11941-126A6	33.47	1.00	3.01	0.00
Melanocyte - dark, donor1	11502-119F8	44.18	6.17	0.80	2.09
Melanocyte - dark, donor2	11582-120F7	47.41	7.27	1.38	1.73
Melanocyte - dark, donor3	11663-122F7	31.29	6.59	3.69	1.67
Melanocyte - light, donor1	11274-116H5	14.57	2.59	0.47	0.47
Melanocyte - light, donor2	11351-117H1	25.93	2.05	2.05	0.00
Melanocyte - light, donor3	11423-118G1	46.83	4.34	4.34	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	24.05	11.77	4.69	2.08
Melanocyte, donor2 (MC+2)	12739-135I3	33.08	12.64	5.38	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	17.68	2.68	0.27	0.00
Meningeal Cells, donor1	11493-119E8	14.89	10.79	3.97	2.85
Meningeal Cells, donor2	11573-120E7	26.41	10.56	4.84	6.60
Meningeal Cells, donor3	11654-122E7	32.60	10.27	6.44	3.50
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	82.70	13.12	7.98	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.59	2.11	2.82	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	34.17	10.51	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	10.47	5.23	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.82	12.20	8.61	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.22	4.02	1.27	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	2.51	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	43.73	10.55	5.49	1.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	42.37	18.26	7.31	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.58	14.12	7.77	2.25
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.92	2.22	3.74	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	34.57	4.46	0.74	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	65.13	4.47	3.82	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	40.95	2.67	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	58.92	9.61	2.56	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	73.72	21.62	12.76	4.96
Mesenchymal stem cells - hepatic, donor0	11218-116B3	100.70	4.07	3.13	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	60.96	29.03	9.43	5.08
Mesothelial Cells, donor1	11247-116E5	28.90	6.36	1.59	1.06
Mesothelial Cells, donor2	12156-128G5	27.03	6.51	1.50	2.00
Mesothelial Cells, donor3	11402-118D7	22.76	4.41	1.08	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	22.96	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.93	4.43	2.96	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.08	3.53	2.94	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	26.04	3.72	1.86	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.20	2.07	2.07	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	13.90	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.78	2.75	1.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.34	1.86	2.33	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.33	2.24	3.66	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	27.72	5.15	3.17	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	29.20	0.88	4.42	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	35.33	1.14	3.80	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	6.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.89	1.49	1.91	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	3.68	1.84	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.90	1.49	1.19	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.09	1.51	2.76	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.25	1.66	1.19	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	3.87	1.66	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.27	1.61	2.30	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.88	2.31	1.68	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.94	2.24	1.02	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.02	1.50	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.79	4.22	1.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.46	1.10	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	4.56	2.53	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	8.28	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.67	1.63	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	3.23	2.35	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	7.63	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.22	1.92	1.44	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.61	2.80	2.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	10.97	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	3.00	2.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	8.15	2.04	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	7.88	2.19	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	13.24	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	14.09	0.00	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.38	3.97	1.24	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	9.74	0.00	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	19.89	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.15	2.39	3.42	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	14.44	3.06	3.06
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	10.65	16.69	1.42	3.91
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	16.83	4.77	1.96	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	9.14	1.25	4.99
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	9.91	0.00	4.66
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	3.32	1.81	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.27	7.93	2.50	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44	7.22	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	10.16	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.09	10.24	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.61	4.56	1.80	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	3.11	1.04	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.01	9.87	1.72	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	11.43	0.00	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.54	4.27	1.87	1.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.67	4.49	2.10	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.43	4.10	0.28	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.19	5.10	0.96	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.46	5.09	1.11	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.96	6.07	0.38	2.65
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	3.41	1.42	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.24	2.21	2.46	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.58	2.35	1.76	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.28	4.32	2.88	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.25	3.30	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.34	1.79	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	0.00	18.83	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.26	1.31	2.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	2.10	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	42.50	1.58	2.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	20.28	1.13	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.84	1.86	2.93	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.33	1.24	2.83	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	26.52	2.21	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.73	1.47	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	23.52	3.21	2.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	2.02	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	1.26	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	66.12	2.54	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	51.02	1.62	4.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	33.23	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	26.28	6.25	3.66	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	3.66	2.09	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	4.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.60	4.17	1.67	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	64.27	10.27	4.56	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	47.88	15.96	0.00	6.38
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	2.04	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	183.76	1.84	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	10.04	0.84	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.80	3.95	1.16	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.54	1.08	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.86	3.36	2.31	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	278.37	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.85	1.99	1.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	41.95	2.98	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	15.64	0.68	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.84	1.31	0.98	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.61	4.01	1.82	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.87	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.47	1.64	1.97	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.96	1.30	0.98	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.75	4.59	2.29	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	0.70	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.53	0.92	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.14	1.61	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	108.98	1.72	3.10	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	316.06	5.06	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.95	5.79	1.11	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	1.27	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.75	2.14	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	1.72	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.66	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.37	9.02	0.90	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.81	1.98	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	36.32	1.51	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.69	1.63	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.95	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	6.78	4.07	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	2.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	14.88	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.16	2.68	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	36.90	3.63	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.02	3.32	1.77	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	189.05	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	1.22	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.79	2.20	1.26	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.16	0.30	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	123.57	3.40	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	293.36	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	35.41	8.82	4.97	1.99
Myoblast, donor2	11322-117D8	38.93	8.06	4.41	1.53
Myoblast, donor3	11398-118D3	41.20	6.22	3.03	2.69
NK T cell leukemia cell line:KHYG-1	10777-110G3	64.36	5.69	3.65	1.17
Natural Killer Cells, donor1	11230-116C6	113.17	0.92	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	82.02	0.60	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	79.14	0.74	1.84	0.37
Neural stem cells, donor1	11275-116H6	16.33	2.18	1.09	0.73
Neural stem cells, donor2	11352-117H2	25.03	1.93	1.93	0.00
Neurons, donor1	11494-119E9	46.65	12.52	3.41	7.97
Neurons, donor2	11574-120E8	38.97	6.16	4.40	2.86
Neurons, donor3	11655-122E8	60.84	9.04	5.76	2.47
Neutrophils, donor1	11233-116C9	10.21	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	11.00	0.61	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	57.94	0.95	1.90	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	30.93	1.63	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	55.15	11.03	4.41	1.40
Olfactory epithelial cells, donor1	11933-125I7	34.83	3.72	1.65	0.69
Olfactory epithelial cells, donor2	11934-125I8	42.84	7.96	3.76	0.58
Olfactory epithelial cells, donor3	11935-125I9	43.25	3.63	1.59	0.68
Olfactory epithelial cells, donor4	11936-126A1	37.98	5.06	2.24	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	49.95	9.03	5.42	3.61
Osteoblast - differentiated, donor1	11276-116H7	45.30	3.40	1.49	0.85
Osteoblast - differentiated, donor2	11353-117H3	65.16	1.14	3.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	115.45	3.72	2.48	1.24
Osteoblast, donor1	11277-116H8	93.42	21.30	9.19	5.86
Osteoblast, donor2	11354-117H4	24.58	11.24	3.51	2.81
Osteoblast, donor3	11426-118G4	45.68	15.64	3.73	3.02
Pancreatic stromal cells, donor1	11249-116E7	40.60	4.80	2.02	0.93
Pericytes, donor1	11491-119E6	28.26	2.23	3.12	0.45
Pericytes, donor2	11571-120E5	55.23	3.17	3.62	1.36
Pericytes, donor3	11652-122E5	51.47	13.63	4.27	2.24
Perineurial Cells, donor1	11499-119F5	51.09	7.01	2.49	2.15
Perineurial Cells, donor2	11579-120F4	38.18	6.07	1.10	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	74.90	1.27	2.23	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	53.14	0.73	0.98	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	57.98	0.78	1.04	0.13
Placental Epithelial Cells, donor1	11278-116H9	75.34	15.55	16.98	4.54
Placental Epithelial Cells, donor2	11355-117H5	34.38	9.98	4.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	58.11	7.07	2.75	2.94
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	34.81	1.27	3.48	0.32
Preadipocyte - breast, donor1	11467-119B9	18.01	2.44	1.31	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.09	1.17	1.17	0.13
Preadipocyte - breast, donor2	11328-117E5	42.55	3.83	3.38	0.23
Preadipocyte - omental, donor1	11468-119C1	20.03	2.13	2.77	0.21
Preadipocyte - omental, donor2	11329-117E6	14.40	3.49	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	30.66	6.73	1.58	1.72
Preadipocyte - perirenal, donor1	11469-119C2	53.15	10.83	2.95	6.89
Preadipocyte - subcutaneous, donor1	11279-116I1	48.22	10.44	7.37	3.69
Preadipocyte - subcutaneous, donor2	11356-117H6	44.45	15.23	5.67	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	57.39	9.54	5.28	4.60
Preadipocyte - visceral, donor1	11280-116I2	33.25	7.45	4.47	1.68
Preadipocyte - visceral, donor2	11357-117H7	23.47	6.90	1.84	0.46
Preadipocyte - visceral, donor3	11429-118G7	50.57	13.79	7.84	3.76
Prostate Epithelial Cells (polarized), donor1	11253-116F2	84.02	13.58	8.00	5.73
Prostate Epithelial Cells, donor2	11331-117E8	28.98	5.96	4.06	2.71
Prostate Epithelial Cells, donor3	11404-118D9	33.74	2.39	2.94	0.31
Prostate Stromal Cells, donor1	11254-116F3	59.34	9.23	6.04	2.05
Prostate Stromal Cells, donor2	11332-117E9	48.77	8.61	7.71	1.26
Prostate Stromal Cells, donor3	11405-118E1	38.79	1.88	2.29	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.21	6.57	3.28	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.96	4.02	2.15	0.76
Renal Epithelial Cells, donor1	11517-119H5	35.51	17.25	7.10	1.52
Renal Epithelial Cells, donor2	11597-120H4	41.97	17.78	4.98	4.27
Renal Epithelial Cells, donor3	11678-122H4	35.78	4.13	2.75	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.96	9.53	4.09	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.85	11.86	4.58	5.12
Renal Glomerular Endothelial Cells, donor3	11675-122H1	23.98	20.20	2.00	8.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	5.99	3.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	46.44	10.56	3.96	2.42
Renal Mesangial Cells, donor2	11598-120H5	45.77	5.64	1.88	1.88
Renal Mesangial Cells, donor3	11679-122H5	41.89	8.88	3.05	2.50
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	36.24	15.84	6.71	3.49
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	32.05	10.12	3.37	3.80
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	37.22	12.92	3.47	3.66
Retinal Pigment Epithelial Cells, donor0	11215-116A9	65.86	14.00	5.44	2.85
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.21	12.79	3.13	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	16.47	1.03	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.85	4.01	3.76	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	38.09	3.21	2.41	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	53.60	7.15	3.57	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	51.18	2.75	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.20	5.80	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.75	19.11	4.03	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.03	16.98	4.17	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	34.35	12.05	4.24	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	34.36	15.38	4.22	5.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.58	12.59	3.85	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	45.76	10.40	3.24	4.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.53	11.91	2.33	6.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	45.53	14.98	4.69	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	53.22	22.04	5.20	5.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.56	13.05	2.58	6.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	44.64	15.67	4.40	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	42.71	13.50	4.87	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	25.81	12.43	2.68	8.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	40.25	18.91	3.45	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.17	7.89	3.19	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.29	20.57	2.65	13.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	34.65	13.04	2.82	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	43.35	11.08	4.20	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.39	15.38	2.46	7.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.17	10.37	2.24	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	29.39	15.72	4.10	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.98	23.34	2.55	8.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	34.46	13.37	3.80	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	51.44	14.10	3.22	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.82	8.26	4.48	6.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	42.86	11.51	2.98	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	60.10	12.86	7.02	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.24	11.40	3.73	7.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	38.93	13.05	2.21	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	40.11	14.83	3.55	4.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.26	11.84	2.42	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.43	24.01	1.87	5.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	41.45	11.76	3.08	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.62	8.94	3.27	5.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	41.29	26.75	3.29	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.13	14.61	4.60	3.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.35	11.93	3.07	6.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	34.33	9.91	3.85	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.59	13.33	1.33	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.08	8.43	1.38	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	52.86	8.10	3.57	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	31.64	9.27	1.01	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	17.05	7.82	1.79	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	63.93	8.04	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	48.05	8.76	3.02	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.75	8.57	2.94	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.76	5.53	2.77	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	56.58	9.73	4.26	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.11	6.33	4.82	4.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.19	8.14	0.90	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	30.85	5.09	1.20	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	15.00	6.14	2.24	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.40	10.25	2.99	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	32.45	7.21	1.20	1.20
Schwann Cells, donor1	11498-119F4	57.93	17.87	13.54	3.39
Schwann Cells, donor2	11578-120F3	20.41	6.80	0.00	6.80
Schwann Cells, donor3	11659-122F3	38.34	9.20	2.41	3.07
Sebocyte, donor1	11220-116B5	37.80	7.12	2.74	0.55
Sebocyte, donor2	11301-117B5	25.74	7.81	1.84	1.84
Sebocyte, donor3	11378-118B1	49.05	5.57	5.98	1.65
Sertoli Cells, donor1	11255-116F4	41.41	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	73.43	2.82	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	60.70	7.39	3.43	0.70
Skeletal Muscle Cells, donor2	11358-117H8	70.12	2.89	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	92.80	37.62	19.23	10.03
Skeletal Muscle Cells, donor4	11451-119A2	81.85	20.74	13.35	5.03
Skeletal Muscle Cells, donor5	11455-119A6	72.98	15.61	13.38	6.39
Skeletal Muscle Cells, donor6	11459-119B1	61.71	21.08	15.39	5.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	74.72	4.41	5.42	0.88
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.36	6.42	7.28	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.97	18.75	7.84	5.75
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	44.82	4.13	1.94	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	66.59	23.16	13.75	13.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	66.05	6.74	7.43	2.89
Skin - palm, donor1	10286-104F7	51.04	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	39.50	5.48	4.90	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	6.54	2.45	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	44.27	3.76	5.19	1.17
Small Airway Epithelial Cells, donor1	11256-116F5	52.68	3.61	6.26	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	54.01	8.16	2.67	1.97
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	34.04	8.88	2.75	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	33.80	4.42	2.17	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.72	5.86	2.78	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.11	2.67	1.56	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	79.36	9.99	8.23	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	32.26	11.27	3.98	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	46.07	12.21	5.51	9.06
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	11.59	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	47.04	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.58	11.58	3.46	3.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	64.06	9.53	5.98	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	59.02	22.53	6.27	14.60
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.72	9.12	5.54	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.14	9.16	3.25	2.36
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	47.41	6.98	2.99	2.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	39.69	9.27	6.51	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.96	4.57	2.13	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	59.10	9.60	4.04	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	403.97	18.36	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	57.22	15.26	9.54	5.72
Smooth Muscle Cells - Colonic, donor1	11239-116D6	60.17	6.93	3.10	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	51.87	5.81	4.09	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	65.28	10.81	5.04	4.09
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	50.27	18.87	4.95	5.26
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	73.30	28.02	5.39	16.17
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	58.28	26.00	6.87	8.37
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	65.89	14.34	6.49	3.07
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	61.33	2.04	2.51	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	17.31	3.12	2.62	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	36.86	8.19	2.50	2.73
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	45.89	16.30	4.83	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	62.52	29.14	9.80	13.25
Smooth Muscle Cells - Prostate, donor1	11257-116F6	30.63	5.59	4.39	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	50.96	3.88	3.38	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	35.77	1.78	2.54	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	47.04	11.46	4.37	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	57.76	4.50	4.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	134.39	23.26	9.05	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	48.37	16.74	6.51	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	40.39	10.60	6.56	3.53
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	32.91	10.97	5.33	6.27
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.68	3.54	2.36	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	78.47	12.08	5.75	3.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	54.66	3.74	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	40.44	9.64	4.61	1.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	79.80	19.89	5.35	7.39
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	55.28	18.05	5.83	6.96
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	60.65	9.36	5.17	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	95.10	6.79	2.60	1.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	31.90	5.24	3.81	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	58.23	13.70	4.40	3.67
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.04	4.42	3.09	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	56.76	6.14	6.14	2.63
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	33.43	3.89	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.65	3.44	1.32	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.37	0.74	3.35	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	35.57	5.03	2.16	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.85	6.25	3.69	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	23.63	9.06	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	38.09	3.30	2.79	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	44.32	2.00	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	44.31	3.34	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	46.29	2.29	0.92	0.46
Synoviocyte, donor1	11291-117A4	24.07	4.04	2.52	0.67
Synoviocyte, donor2	11368-117I9	71.41	1.51	1.84	0.67
Synoviocyte, donor3	11440-118H9	46.69	2.68	3.13	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	26.80	13.94	4.29	5.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	11.89	5.95	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	33.34	11.58	3.70	4.63
Tracheal Epithelial Cells, donor1	11292-117A5	50.18	11.97	4.73	2.44
Tracheal Epithelial Cells, donor2	11369-118A1	85.43	20.87	6.19	6.57
Tracheal Epithelial Cells, donor3	11441-118I1	64.71	22.91	9.16	13.17
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	33.22	2.34	2.09	0.25
Urethra, donor2	10319-105A4	41.36	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	31.08	5.58	5.31	2.39
Urothelial Cells, donor2	11600-120H7	28.44	8.01	3.61	0.40
Urothelial Cells, donor3	11681-122H7	32.55	7.11	2.75	1.38
Urothelial cells, donor0	11216-116B1	55.06	5.13	5.57	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.90	1.78	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	4.29	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	21.69	0.00	1.72	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	30.79	0.58	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	2.08	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	10.10	0.92	3.67	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	45.03	15.91	5.18	7.03
Wilms' tumor cell line:HFWT	10597-108E3	44.88	16.72	1.76	3.52
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	55.86	7.82	6.98	0.28
achilles tendon, donor2	10292-104G4	33.06	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	70.62	20.40	6.37	2.80
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	82.89	16.72	8.59	7.66
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	53.42	3.44	2.85	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	59.59	23.67	12.25	7.62
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.17	4.50	3.09	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	62.18	5.50	3.81	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.94	1.63	1.91	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	114.13	14.10	11.90	10.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	61.25	5.31	6.94	3.68
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	149.11	9.32	6.60	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	108.19	37.90	25.76	13.43
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	23.40	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	68.79	17.89	6.97	9.99
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	66.02	17.86	13.72	7.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	58.74	13.74	14.32	4.97
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	47.41	8.37	8.37	2.79
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.49	3.29	7.40	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	118.18	26.70	17.50	11.05
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	90.46	14.08	17.50	4.27
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.98	11.53	15.47	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	97.25	14.68	19.74	2.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.32	14.92	13.59	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	30.35	16.68	8.01	5.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	40.88	14.87	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	43.32	9.42	11.68	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	46.67	10.47	7.41	3.49
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	149.96	31.87	1.87	5.62
adenocarcinoma cell line:IM95m	10796-110I4	38.86	11.77	2.35	2.83
adipose tissue, adult, pool1	10010-101C1	35.52	3.26	3.57	0.16
adipose, donor1	10184-103D4	359.47	17.01	9.97	4.10
adipose, donor2	10185-103D5	61.23	6.89	2.43	0.41
adipose, donor3	10186-103D6	106.19	14.43	7.08	5.45
adipose, donor4	10187-103D7	99.68	44.20	9.53	18.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	42.30	12.94	4.42	3.95
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.91	3.20	6.00	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	86.47	32.51	4.64	6.07
amniotic membrane cells, donor1	12235-129G3	62.83	3.71	4.17	0.93
amniotic membrane cells, donor2	12236-129G4	82.50	7.10	5.75	1.01
amniotic membrane cells, donor3	12237-129G5	81.60	3.54	10.02	2.06
amygdala - adult, donor10196	10167-103B5	11.86	3.56	1.19	0.00
amygdala, adult, donor10252	10151-102I7	29.20	5.88	2.43	2.64
amygdala, newborn, donor10223	10360-105E9	18.40	3.23	3.23	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	47.88	1.15	1.15	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	163.48	43.02	23.39	15.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	86.52	8.02	1.67	4.68
aorta, adult, pool1	10052-101G7	32.56	1.37	1.77	0.20
appendix, adult	10189-103D9	55.89	4.66	3.10	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	116.94	13.07	9.29	3.44
artery, adult	10190-103E1	40.76	1.36	5.43	0.00
astrocytoma cell line:TM-31	10425-106D2	41.00	5.65	1.30	0.87
b cell line:RPMI1788	10427-106D4	58.14	4.01	5.20	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	33.02	3.61	2.50	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	59.04	10.82	9.53	1.59
bile duct carcinoma cell line:TFK-1	10496-107C1	49.38	11.55	6.36	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	104.58	2.24	8.39	0.00
bladder, adult, pool1	10011-101C2	58.67	2.50	2.17	0.00
blood, adult, pool1	10053-101G8	31.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	6.85	0.00	0.00
bone marrow, adult	10192-103E3	29.69	2.02	0.67	0.67
brain, adult, donor1	10084-102B3	21.53	4.10	1.03	3.08
brain, adult, pool1	10012-101C3	24.39	3.79	4.12	1.11
brain, fetal, pool1	10085-102B4	24.04	2.67	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	134.46	15.20	5.95	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	30.46	6.87	1.87	0.25
breast, adult, donor1	10080-102A8	15.78	1.26	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	52.59	10.16	8.64	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	51.64	10.20	3.40	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	93.24	4.60	13.58	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	67.30	10.65	8.72	1.21
carcinoid cell line:NCI-H1770	10703-109H1	52.19	6.11	4.23	0.94
carcinoid cell line:NCI-H727	10735-110B6	77.33	10.94	7.98	2.30
carcinoid cell line:SK-PN-DW	10719-109I8	77.96	16.48	4.12	4.44
carcinosarcoma cell line:JHUCS-1	10642-109A3	56.70	6.12	3.99	2.93
caudate nucleus - adult, donor10196	10177-103C6	8.06	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.42	2.68	2.51	0.67
caudate nucleus, adult, donor10258	10379-105H1	9.93	0.76	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	30.03	3.30	3.30	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	20.07	2.99	1.71	0.64
cerebellum, adult, pool1	10083-102B2	15.18	1.38	3.10	0.69
cerebellum, newborn, donor10223	10357-105E6	29.89	1.66	1.66	0.00
cerebral meninges, adult	10188-103D8	35.80	6.05	3.53	1.76
cerebrospinal fluid, donor2	10294-104G6	21.93	2.92	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	116.61	8.77	15.82	1.73
cervical cancer cell line:ME-180	10553-107I4	67.94	7.95	4.47	1.16
cervix, adult, pool1	10013-101C4	75.28	2.52	3.57	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	49.47	6.55	5.02	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	30.04	13.06	1.31	3.92
choriocarcinoma cell line:BeWo	10423-106C9	119.43	12.30	13.42	2.24
choriocarcinoma cell line:SCH	10785-110H2	61.85	9.36	4.07	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	87.28	24.90	15.18	6.88
chorionic membrane cells, donor1	12238-129G6	65.53	3.99	3.13	0.57
chorionic membrane cells, donor2	12239-129G7	52.80	7.66	3.48	0.99
chorionic membrane cells, donor3	12240-129G8	65.94	2.75	7.14	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	63.62	6.06	16.16	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	84.72	14.98	8.84	3.65
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	105.38	11.40	4.65	4.01
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	21.31	19.52	5.39	4.88
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	20.32	22.98	4.84	6.29
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	29.12	12.42	7.33	3.87
chronic myelogenous leukemia cell line:K562	10454-106G4	70.67	32.98	25.91	5.30
chronic myelogenous leukemia cell line:KU812	10409-106B4	44.83	9.90	3.39	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	57.37	7.54	6.63	3.66
clear cell carcinoma cell line:TEN	10636-108I6	104.10	8.33	7.63	1.74
colon carcinoma cell line:CACO-2	10513-107D9	71.75	19.95	12.45	7.69
colon carcinoma cell line:COLO-320	10420-106C6	48.27	4.56	3.04	1.90
colon, adult, donor1	10082-102B1	49.98	2.38	2.38	0.00
colon, adult, pool1	10014-101C5	55.23	2.47	2.70	1.06
colon, fetal, donor1	10070-101I7	40.17	0.00	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	114.59	41.25	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	500.73	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	58.22	7.65	5.52	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	62.18	15.55	12.07	3.02
cord blood derived cell line:COBL-a untreated	10449-106F8	60.21	16.08	9.73	2.68
corpus callosum, adult, pool1	10042-101F6	20.56	2.54	3.21	0.11
cruciate ligament, donor2	10295-104G7	39.71	3.24	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	36.92	3.21	0.80	0.00
diencephalon, adult	10193-103E4	18.00	2.16	3.36	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	121.01	15.61	6.20	3.67
ductal cell carcinoma cell line:KLM-1	10438-106E6	71.29	13.33	15.64	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.90	7.46	1.93	1.93
ductus deferens, adult	10196-103E7	34.39	3.49	1.99	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	61.93	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.10	2.21	2.94	0.00
dura mater, adult, donor1	10041-101F5	29.90	0.58	2.31	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	52.85	31.31	7.77	13.32
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	70.50	23.93	11.03	9.74
embryonic pancreas cell line:1B2C6	10604-108F1	51.80	18.50	3.08	3.08
embryonic pancreas cell line:1C3D3	10605-108F2	74.77	7.57	3.03	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	60.21	26.24	5.56	2.47
embryonic pancreas cell line:2C6	10603-108E9	61.73	27.58	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	51.96	34.19	5.70	5.36
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.79	3.26	2.90	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.17	9.33	3.38	3.06
epidermoid carcinoma cell line:A431	10426-106D3	37.13	12.34	5.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.76	6.16	2.64	1.32
epididymis, adult	10197-103E8	45.00	2.51	3.14	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	35.30	4.97	4.26	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.07	12.19	5.11	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	65.39	21.36	9.30	12.19
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	60.73	18.90	6.40	7.58
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	69.35	22.97	8.51	11.76
esophagus, adult, pool1	10015-101C6	49.16	4.25	2.12	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	64.37	6.39	2.13	0.88
eye - muscle inferior rectus, donor1	10272-104E2	57.95	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	31.56	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	20.84	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	30.96	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	5.83	1.46	0.00
eye, fetal, donor1	10054-101G9	39.41	0.76	2.54	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	64.75	12.18	6.03	4.62
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	103.51	55.56	13.53	22.79
frontal lobe, adult, pool1	10040-101F4	14.07	1.60	2.16	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.62	15.91	3.90	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	33.83	4.02	4.85	0.55
gall bladder, adult	10198-103E9	37.90	2.66	1.93	0.72
gamma delta positive T cells, donor1	11937-126A2	166.42	1.07	3.22	0.54
gamma delta positive T cells, donor2	11938-126A3	112.42	0.75	5.23	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	68.01	12.67	7.18	4.22
gastric adenocarcinoma cell line:MKN45	10612-108F9	103.48	14.89	7.93	3.48
gastric cancer cell line:AZ521	10549-107H9	67.22	18.04	6.72	5.90
gastric cancer cell line:GSS	10560-108A2	21.05	2.75	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.95	5.94	1.83	1.83
giant cell carcinoma cell line:LU65	10487-107B1	66.32	15.03	19.62	2.98
giant cell carcinoma cell line:Lu99B	10433-106E1	76.98	3.78	4.06	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	42.90	8.98	6.24	3.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.24	11.51	4.64	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.23	16.71	3.93	0.98
glioblastoma cell line:T98G	10485-107A8	52.87	9.38	7.06	1.10
glioma cell line:GI-1	10413-106B8	33.10	4.69	2.05	0.00
globus pallidus - adult, donor10196	10175-103C4	8.75	2.92	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	31.73	2.44	2.20	0.73
globus pallidus, adult, donor10258	10367-105F7	16.43	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	28.24	4.80	2.13	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	29.37	2.45	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	313.59	20.91	36.59	10.45
granulosa cell tumor cell line:KGN	10624-108H3	40.64	8.00	1.92	2.24
hIPS +CCl2, biol_rep1	14383-156B9	39.02	39.94	4.13	24.33
hIPS +CCl2, biol_rep2	14384-156C1	22.86	30.18	2.29	18.75
hIPS +CCl2, biol_rep3	14385-156C2	35.43	57.97	7.73	23.83
hIPS, biol_rep1	14380-156B6	23.00	103.48	5.75	5.75
hIPS, biol_rep2	14381-156B7	30.18	74.76	4.80	34.29
hIPS, biol_rep3	14382-156B8	6.62	7.72	1.10	8.83
hairy cell leukemia cell line:Mo	10712-109I1	30.46	5.46	4.02	0.86
heart - mitral valve, adult	10205-103F7	23.62	3.89	2.39	0.60
heart - pulmonic valve, adult	10206-103F8	26.93	1.83	2.35	0.00
heart - tricuspid valve, adult	10207-103F9	29.98	17.49	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	31.02	3.67	2.86	1.43
heart, adult, diseased, donor1	10051-101G6	18.74	0.85	3.41	0.85
heart, adult, pool1	10016-101C7	35.88	4.83	1.61	1.15
heart, fetal, pool1	10046-101G1	29.57	3.39	1.85	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	32.40	10.80	0.62	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	107.03	73.73	5.95	17.84
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	41.66	38.34	3.20	23.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	44.42	31.92	3.52	26.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	39.51	31.23	2.63	21.73
hepatoma cell line:Li-7	10484-107A7	39.70	16.57	2.89	3.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	73.47	21.31	6.73	7.44
hippocampus - adult, donor10196	10169-103B7	12.30	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	25.72	4.08	3.27	1.63
hippocampus, adult, donor10258	10374-105G5	6.97	3.98	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	17.27	2.82	2.11	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	301.51	50.66	26.86	21.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	131.75	44.57	19.24	20.42
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	176.71	37.32	19.04	15.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	150.55	9.59	6.20	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	147.96	8.26	7.75	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	222.45	7.97	13.29	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	148.31	5.84	8.17	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	143.26	4.09	6.68	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	103.85	6.26	5.42	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	152.26	4.03	9.95	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	131.63	7.39	10.61	2.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	131.29	7.41	7.41	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	108.29	39.90	14.87	18.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	81.55	49.13	11.30	23.58
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	172.81	45.38	37.53	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	109.77	6.11	4.96	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	78.93	7.41	4.80	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	154.43	10.00	4.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	109.08	2.83	6.22	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	101.40	2.73	7.28	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	110.89	3.76	5.95	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	85.08	8.00	7.02	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	78.96	4.64	9.58	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	82.50	9.27	4.18	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	104.93	42.12	18.66	15.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	78.17	41.94	15.98	18.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	199.66	64.51	30.22	18.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	85.20	10.91	6.69	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	70.32	8.24	6.33	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	101.08	9.08	8.17	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	74.98	6.21	7.76	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	81.69	5.98	6.64	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	101.07	5.39	7.70	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	70.81	7.16	12.02	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	74.21	8.33	6.06	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	78.64	11.43	10.42	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	96.60	35.74	19.56	18.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	139.49	45.90	32.09	11.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	126.34	53.17	20.49	15.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	73.35	3.36	5.50	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	832.83	6.51	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	183.01	8.27	11.91	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	63.49	4.38	5.47	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	100.24	3.98	7.60	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	83.27	3.20	8.54	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	8.35	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	71.50	3.93	7.31	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	83.24	8.35	7.54	1.35
immature langerhans cells, donor1	11904-125F5	41.89	0.24	2.91	0.24
immature langerhans cells, donor2	11905-125F6	72.08	1.58	3.96	0.00
insula, adult, pool1	10039-101F3	15.71	3.88	2.74	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	69.58	10.08	4.55	6.18
kidney, adult, pool1	10017-101C8	34.74	3.50	2.40	0.50
kidney, fetal, pool1	10045-101F9	32.75	3.82	1.56	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	74.99	24.00	6.39	7.67
large cell lung carcinoma cell line:NCI-H460	10839-111E2	111.98	8.99	6.08	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	74.87	9.36	6.97	2.02
left atrium, adult, donor1	10079-102A7	28.88	0.00	1.63	0.54
left ventricle, adult, donor1	10078-102A6	23.26	2.53	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	82.63	25.72	2.74	7.66
leiomyoma cell line:10964C	10569-108B2	49.22	2.87	5.03	1.44
leiomyoma cell line:15242A	10570-108B3	44.02	6.52	5.43	3.26
leiomyoma cell line:15425	10571-108B4	33.51	5.10	5.10	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	42.87	7.32	6.27	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	110.38	19.13	6.38	5.31
liposarcoma cell line:KMLS-1	10782-110G8	43.58	4.84	2.34	0.62
liposarcoma cell line:SW 872	10726-110A6	46.42	11.33	2.07	4.26
liver, adult, pool1	10018-101C9	34.03	6.97	3.08	0.81
liver, fetal, pool1	10086-102B5	16.93	4.70	6.58	2.82
locus coeruleus - adult, donor10196	10182-103D2	14.29	3.21	1.90	0.29
locus coeruleus, adult, donor10252	10165-103B3	26.02	3.32	2.21	0.74
locus coeruleus, adult, donor10258	10375-105G6	23.14	0.85	2.82	0.28
locus coeruleus, newborn, donor10223	10362-105F2	31.97	3.36	7.57	0.42
lung adenocarcinoma cell line:A549	10499-107C4	44.15	13.84	4.01	1.80
lung adenocarcinoma cell line:PC-14	10408-106B3	64.80	14.48	8.27	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	48.51	20.04	4.09	2.90
lung, adult, pool1	10019-101D1	48.43	1.65	1.89	0.12
lung, fetal, donor1	10068-101I5	13.98	3.14	3.14	0.86
lung, right lower lobe, adult, donor1	10075-102A3	29.33	1.83	3.21	0.00
lymph node, adult, donor1	10077-102A5	53.96	2.37	2.37	0.95
lymphangiectasia cell line:DS-1	10727-110A7	87.01	5.70	3.95	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	60.52	4.38	7.40	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	2.55	3.40	0.00
mature adipocyte, donor1	12231-129F8	43.07	2.66	1.33	0.44
mature adipocyte, donor2	12232-129F9	34.45	1.66	2.49	0.21
mature adipocyte, donor3	12233-129G1	29.63	1.90	2.61	0.24
mature adipocyte, donor4	12234-129G2	47.38	1.05	2.37	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	58.61	10.25	5.00	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	11.28	5.64	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	24.09	4.23	1.66	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	11.44	7.31	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	43.93	3.41	4.26	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	23.12	6.08	2.70	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	23.98	7.00	1.70	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	17.95	3.23	2.87	0.00
medulla oblongata - adult, donor10196	10174-103C3	13.63	1.95	3.24	1.30
medulla oblongata, adult, donor10252	10155-103A2	24.46	2.01	1.55	0.77
medulla oblongata, adult, pool1	10038-101F2	11.43	1.47	3.27	0.24
medulla oblongata, newborn, donor10223	10361-105F1	19.79	4.51	2.08	0.69
medulloblastoma cell line:D283 Med	10838-111E1	73.51	7.09	2.88	1.33
medulloblastoma cell line:ONS-76	10759-110E3	40.84	32.52	3.42	7.34
melanoma cell line:COLO 679	10514-107E1	38.96	13.94	3.74	3.31
melanoma cell line:G-361	10465-106H6	22.80	3.26	1.90	0.81
meningioma cell line:HKBMM	10691-109F7	73.27	6.69	5.79	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	53.75	15.86	5.29	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	22.81	4.15	2.07	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	67.97	9.97	6.60	3.22
mesenchymal precursor cell - adipose, donor2	11748-123G2	62.90	4.00	2.73	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.92	7.04	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	44.95	2.39	1.26	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	51.61	5.58	1.54	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	2.08	3.47	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	59.04	2.92	2.40	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	50.38	3.45	1.96	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	39.79	7.30	4.64	1.33
mesenchymal precursor cell - cardiac, donor4	11755-123G9	39.43	8.10	3.11	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.43	8.82	1.85	3.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.86	1.98	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.57	9.55	4.15	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.02	6.63	2.79	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	44.10	4.29	3.67	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.36	1.44	2.16	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.62	3.00	2.69	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.34	5.93	2.51	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.08	7.97	7.13	7.13
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.00	5.53	2.69	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.17	5.78	1.66	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	1.84	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.32	3.43	0.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.68	3.37	4.63	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.16	0.91	0.91	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	31.72	2.56	3.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	27.75	3.14	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	31.12	3.39	1.23	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.83	2.59	2.35	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.34	2.71	3.72	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.94	2.36	1.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	1.85	3.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.07	4.90	3.46	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.76	2.45	2.68	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.80	2.40	1.20	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	40.33	2.20	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.82	2.35	0.67	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.88	3.68	3.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.06	5.58	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	49.22	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	45.79	4.22	2.60	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	46.91	4.80	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	44.16	4.91	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	41.20	2.33	1.55	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	6.30	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	40.73	3.97	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	33.80	3.56	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	37.77	4.87	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.90	4.43	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.01	3.79	0.69	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	2.15	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.97	3.26	1.63	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	60.38	4.77	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	53.06	1.77	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.92	5.92	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	42.77	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	5.91	2.37	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	58.51	8.26	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	48.49	4.95	3.96	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	58.32	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	45.80	3.82	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	37.07	4.43	2.01	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	4.36	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.81	3.03	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.12	1.65	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	45.24	2.18	1.19	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	38.29	1.95	2.92	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	48.89	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.12	7.74	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	87.65	32.13	15.83	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	35.91	6.49	2.09	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	8.55	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	114.98	18.50	11.51	8.94
mesothelioma cell line:Mero-25	10850-111F4	36.77	17.70	7.94	5.22
mesothelioma cell line:Mero-41	10851-111F5	33.49	6.36	7.58	0.73
mesothelioma cell line:Mero-48a	10852-111F6	39.19	13.73	4.21	3.99
mesothelioma cell line:Mero-82	10853-111F7	48.62	22.60	4.47	9.46
mesothelioma cell line:Mero-83	10854-111F8	28.26	11.58	3.92	2.89
mesothelioma cell line:Mero-84	10855-111F9	37.92	12.64	6.32	2.02
mesothelioma cell line:Mero-95	10856-111G1	30.44	6.83	3.52	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	30.81	9.61	4.97	2.82
mesothelioma cell line:NCI-H226	10846-111E9	30.95	16.65	4.16	7.24
mesothelioma cell line:NCI-H2452	10848-111F2	34.51	10.42	5.64	0.68
mesothelioma cell line:NCI-H28	10845-111E8	43.00	10.43	8.40	3.56
mesothelioma cell line:No36	10857-111G2	24.47	11.74	2.94	1.96
mesothelioma cell line:ONE58	10858-111G3	18.42	8.67	3.52	0.81
migratory langerhans cells, donor1	11901-125F2	18.62	0.77	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	16.24	0.37	0.85	0.00
migratory langerhans cells, donor3	11903-125F4	38.05	0.90	1.26	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	39.18	9.47	3.26	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.18	19.92	2.76	7.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	105.73	31.10	9.91	6.45
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	65.65	4.00	4.19	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	109.58	8.50	9.42	2.03
myeloma cell line:PCM6	10474-106I6	74.92	2.37	2.97	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.64	33.48	2.54	10.65
myxofibrosarcoma cell line:NMFH-1	10684-109E9	49.43	6.67	4.12	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	66.97	2.90	6.91	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	52.07	3.02	7.72	0.37
nasal epithelial cells, donor2	12227-129F4	33.67	1.10	5.52	0.55
neuroblastoma cell line:CHP-134	10508-107D4	110.66	11.96	6.21	2.53
neuroblastoma cell line:NB-1	10539-107G8	49.95	9.35	4.12	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	51.88	23.20	4.22	6.12
neuroblastoma cell line:NH-12	10555-107I6	128.58	10.62	5.22	3.73
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	61.92	1.90	2.61	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	112.61	6.49	6.18	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	102.64	3.82	3.02	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	105.54	20.98	8.26	5.72
neurofibroma cell line:Hs 53.T	10729-110A9	36.46	13.04	2.40	1.60
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	64.10	3.38	2.88	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.82	8.01	7.20	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.11	3.53	3.53	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.67	5.26	4.99	0.53
nucleus accumbens, adult, pool1	10037-101F1	14.25	3.09	2.62	0.37
occipital cortex - adult, donor10196	10172-103C1	12.36	6.18	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	27.10	7.51	2.95	1.34
occipital cortex, newborn, donor10223	10355-105E4	14.92	4.73	4.37	1.46
occipital lobe, adult, donor1	10076-102A4	19.42	3.41	4.20	1.31
occipital lobe, fetal, donor1	10073-102A1	35.62	3.00	2.15	1.29
occipital pole, adult, pool1	10036-101E9	12.22	3.07	1.50	0.32
olfactory region, adult	10195-103E6	14.90	4.78	2.29	1.34
optic nerve, donor1	10277-104E7	24.01	2.00	6.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.20	7.06	3.19	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	54.27	10.17	7.28	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	57.06	9.31	2.88	2.54
oral squamous cell carcinoma cell line:SAS	10544-107H4	56.71	9.59	3.93	3.00
osteoclastoma cell line:Hs 706.T	10704-109H2	33.81	2.94	2.94	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	208.36	57.93	25.23	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	59.59	7.21	2.97	1.27
ovary, adult, pool1	10020-101D2	72.07	2.88	2.80	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.58	15.22	2.38	5.68
pancreas, adult, donor1	10049-101G4	346.16	6.58	9.41	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	80.51	11.74	8.67	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	53.32	4.26	4.77	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	31.46	3.31	1.99	0.33
paracentral gyrus, adult, pool1	10035-101E8	11.35	2.75	3.20	0.55
parietal cortex, adult, donor10258	10373-105G4	12.48	1.47	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	12.23	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	18.81	5.99	0.57	2.85
parietal lobe, adult, pool1	10034-101E7	14.28	3.52	2.03	1.06
parietal lobe, fetal, donor1	10072-101I9	40.73	1.94	4.85	0.97
parietal lobe, newborn, donor10223	10356-105E5	22.06	6.73	3.74	1.12
parotid gland, adult	10199-103F1	56.12	1.85	1.23	0.00
penis, adult	10200-103F2	35.99	1.61	2.69	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	45.93	2.42	8.18	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.87	8.30	3.21	1.17
pineal gland - adult, donor10196	10179-103C8	10.32	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	16.58	2.96	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	6.90	1.88	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	14.17	5.06	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	23.97	5.73	2.08	1.56
pituitary gland, adult, donor10258	10378-105G9	22.13	2.55	8.51	0.00
placenta, adult, pool1	10021-101D3	36.34	2.26	4.95	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	73.36	7.15	9.67	1.72
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	40.78	3.11	2.18	0.47
pons, adult, pool1	10033-101E6	12.39	1.46	1.89	0.00
postcentral gyrus, adult, pool1	10032-101E5	17.35	2.70	2.53	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	71.11	27.19	6.27	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	198.29	5.51	22.03	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	234.72	23.47	11.74	23.47
prostate cancer cell line:DU145	10490-107B4	52.88	12.67	8.01	3.64
prostate cancer cell line:PC-3	10439-106E7	43.74	16.34	4.36	2.00
prostate, adult, pool1	10022-101D4	49.79	2.18	2.63	0.54
putamen, adult, donor10196	10176-103C5	29.27	2.83	4.01	0.47
putamen, adult, donor10252	10152-102I8	49.02	1.96	9.80	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	8.74	3.28	6.56
putamen, adult, donor10258, tech_rep2	10372-105G3	14.01	1.45	2.42	0.48
putamen, newborn, donor10223	10365-105F5	40.48	1.50	3.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	73.32	18.91	7.27	3.49
rectum, fetal, donor1	10067-101I4	31.99	4.17	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	33.28	2.76	5.94	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.10	1.66	3.31	0.41
retina, adult, pool1	10030-101E3	34.59	0.89	1.99	0.60
retinoblastoma cell line:Y79	10475-106I7	94.05	6.75	7.01	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	52.01	16.48	2.09	5.78
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	90.83	23.62	7.03	5.34
sacrococcigeal teratoma cell line:HTST	10695-109G2	72.00	3.79	4.55	0.00
salivary acinar cells, donor1	11771-123I7	54.87	4.21	0.65	0.16
salivary acinar cells, donor2	11772-123I8	46.26	1.93	1.51	0.55
salivary acinar cells, donor3	11773-123I9	68.85	3.97	3.31	1.32
salivary gland, adult, pool1	10093-102C3	18.87	3.43	3.43	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	37.01	3.12	4.30	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.26	4.70	3.76	1.29
seminal vesicle, adult	10201-103F3	28.04	3.17	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	49.80	13.36	6.56	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.92	2.52	1.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	17.06	10.04	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	53.33	6.72	1.75	2.69
signet ring carcinoma cell line:Kato III	10436-106E4	37.91	3.09	2.98	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.22	10.58	6.84	2.45
skeletal muscle - soleus muscle, donor1	10282-104F3	57.46	2.84	11.35	0.00
skeletal muscle, adult, pool1	10023-101D5	50.49	2.16	7.08	0.12
skeletal muscle, fetal, donor1	10066-101I3	50.25	4.02	0.00	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	65.02	5.05	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	45.69	21.01	8.34	8.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	34.67	3.78	0.32	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	96.57	6.75	8.29	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	84.39	11.54	5.60	2.64
small cell lung carcinoma cell line:NCI-H82	10842-111E5	55.81	2.90	9.17	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	9.81	5.01	0.44	1.31
small intestine, adult, pool1	10024-101D6	53.03	2.51	1.79	0.36
small intestine, fetal, donor1	10064-101I1	56.51	4.42	4.42	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	2.56	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	40.06	1.81	2.58	0.00
somatostatinoma cell line:QGP-1	10781-110G7	50.12	9.11	1.34	0.00
spinal cord - adult, donor10196	10181-103D1	26.38	3.90	3.90	0.00
spinal cord, adult, donor10252	10159-103A6	18.92	1.97	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	9.69	0.69	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	23.78	4.27	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	37.20	4.59	2.30	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.01	10.60	2.24	2.84
spleen, adult, pool1	10025-101D7	42.40	4.85	2.31	0.99
spleen, fetal, pool1	10044-101F8	17.48	3.42	1.59	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	45.75	3.73	4.55	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	53.55	13.48	3.99	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.31	8.74	2.10	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	95.00	24.63	13.68	10.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	61.34	7.09	13.62	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	10.17	4.24	3.39	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	9.31	7.19	2.12	1.27
stomach, fetal, donor1	10062-101H8	95.05	13.88	3.20	2.14
submaxillary gland, adult	10202-103F4	37.03	5.13	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.87	3.32	3.32	0.42
substantia nigra, adult, donor10258	10371-105G2	4.14	2.59	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	10.60	5.65	4.24	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	95.37	26.59	9.40	5.50
temporal lobe, adult, pool1	10031-101E4	17.04	4.32	3.14	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.17	4.27	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.92	4.83	1.32	0.88
tenocyte, donor1	11763-123H8	31.77	5.93	2.44	0.35
tenocyte, donor2	11765-123I1	41.58	3.05	1.53	1.14
tenocyte, donor3	11768-123I4	23.35	8.15	2.97	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	61.36	43.00	9.52	18.70
teratocarcinoma cell line:NCR-G1	10798-110I6	93.57	33.76	10.17	16.34
teratocarcinoma cell line:PA-1	10807-111A6	68.19	10.85	9.76	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	81.25	18.66	12.19	9.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	38.57	5.29	7.56	4.16
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	121.39	9.05	17.34	5.13
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.98	19.22	9.77	3.58
testis, adult, pool1	10026-101D8	52.51	2.36	3.97	0.21
testis, adult, pool2	10096-102C6	22.10	6.32	5.41	0.90
thalamus - adult, donor10196	10168-103B6	22.08	4.42	1.10	0.00
thalamus, adult, donor10252	10154-103A1	25.94	1.88	2.97	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.35	0.99	2.14	0.00
thalamus, newborn, donor10223	10366-105F6	13.81	5.18	1.15	0.00
throat, adult	10209-103G2	37.95	1.25	2.00	0.00
throat, fetal, donor1	10061-101H7	59.42	3.05	1.83	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	65.98	11.33	6.96	2.58
thymus, adult, pool1	10027-101D9	61.34	3.78	4.37	1.49
thymus, fetal, pool1	10043-101F7	31.48	2.29	2.70	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	49.86	15.69	7.84	3.59
thyroid carcinoma cell line:TCO-1	10783-110G9	112.31	16.76	9.92	3.77
thyroid, adult, pool1	10028-101E1	75.02	4.29	3.92	0.65
thyroid, fetal, donor1	10060-101H6	31.90	3.95	3.16	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	6.16	6.16	0.00
tongue, adult	10203-103F5	37.91	5.35	4.19	0.93
tongue, fetal, donor1	10059-101H5	46.11	2.36	3.55	0.39
tonsil, adult, pool1	10047-101G2	53.99	3.91	3.11	0.50
trachea, adult, pool1	10029-101E2	35.34	5.15	2.70	1.06
trachea, fetal, donor1	10058-101H4	57.32	6.92	2.31	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	51.02	9.92	3.54	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	34.45	6.48	2.74	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	78.97	7.05	7.83	0.94
tridermal teratoma cell line:HGRT	10694-109G1	89.42	24.73	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	65.77	6.43	3.72	1.35
umbilical cord, fetal, donor1	10057-101H3	12.52	6.26	6.26	0.00
uterus, adult, pool1	10100-102D1	25.25	2.05	2.73	0.00
uterus, fetal, donor1	10055-101H1	58.87	3.58	1.54	3.58
vagina, adult	10204-103F6	33.60	5.17	1.29	0.65
vein, adult	10191-103E2	46.91	1.97	2.19	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	77.97	5.07	3.47	2.40